Immune Repertoire Profiling Startup MLC Dx Raises $6M in Private Funding Round

Company executives have a patent pending that describes methods “for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions,” according to the recently published patent application.